title: Temporal lobe volumes in patients with hippocampal sclerosis with or without cortical dysplasia.
abstract: BACKGROUND
  Recent MRI-based volume reconstruction studies in intractable temporal lobe epilepsy (TLE) due to hippocampal sclerosis (HS) suggested atrophy that extends to the adjacent neocortical areas.
  
  
  OBJECTIVE
  To study the extent of temporal lobe volume (TLV) abnormalities in patients with pathologically confirmed HS (with or without cortical dysplasia [CD]) who underwent anterior temporal lobectomy for the treatment of drug-resistant TLE.
  
  
  METHODS
  Fifty patients (right TLE: n = 24; left TLE: n = 26) were found to have HS (hippocampal cell loss of >30%). Associated neocortical CD was seen in 20 patients (43%). MRI-based TLVs and hippocampal and hemispheric volume reconstructions in all patients were compared between pathologic groups and with volumes acquired from 10 age-matched control subjects.
  
  
  RESULTS
  TLVs ipsilateral to the epileptogenic zone in patients with TLE were smaller than TLVs in control subjects (p < 0.01). In patients with left TLE, TLVs ipsilateral to the epileptogenic zone were smaller than contralateral TLVs (left: 66.6 +/- 8.3 cm3, right: 74.9 +/- 10.0 cm3; p < 0.001). In patients with right TLE, there were no significant asymmetries. The contralateral TLVs (regardless of the side of surgery) were smaller in the HS + CD group than the HS group (HS + CD group: 74.9 +/- 8.6 cm3, HS group: 79.7 +/- 6.6 cm3; p < 0.05). Patients with HS + CD had a tendency to have less hippocampal atrophy and slightly smaller TLVs ipsilateral to the epileptogenic zone, accounting for significantly smaller TLV/hippocampal volume ratios compared with patients with HS alone.
  
  
  CONCLUSIONS
  Drug-resistant TLE due to HS is associated with extrahippocampal temporal lobe atrophy. The presence of bilateral temporal lobe atrophy is suggestive of a more widespread (bilateral) temporal lobe involvement in patients with HS and CD.
authors.affiliation: Department of Neurology, The Cleveland Clinic Foundation, OH 44195, USA. diehlb@ccf.org
authors.forename: B
authors.initials: B
authors.lastname: Diehl
authors.forename: I
authors.initials: I
authors.lastname: Najm
authors.forename: E
authors.initials: E
authors.lastname: LaPresto
authors.forename: R
authors.initials: R
authors.lastname: Prayson
authors.forename: P
authors.initials: P
authors.lastname: Ruggieri
authors.forename: A
authors.initials: A
authors.lastname: Mohamed
authors.forename: Z
authors.initials: Z
authors.lastname: Ying
authors.forename: M
authors.initials: M
authors.lastname: Lieber
authors.forename: T
authors.initials: T
authors.lastname: Babb
authors.forename: W
authors.initials: W
authors.lastname: Bingaman
authors.forename: H O
authors.initials: HO
authors.lastname: Lüders
mesh_terms: D000293:Adolescent; D000328:Adult; D038481:Anterior Temporal Lobectomy; D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use; D001284:Atrophy; D002452:Cell Count; D002540:Cerebral Cortex / Q000002:abnormalities*; D002648:Child; D003131:Combined Modality Therapy; D004351:Drug Resistance; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D005260:Female; D006624:Hippocampus / Q000473:pathology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009474:Neurons / Q000473:pathology; D009929:Organ Size; D012598:Sclerosis; D013702:Temporal Lobe / Q000473:pathology*
chemical_list: D000927:Anticonvulsants